
Edward James Tanner III MD MBA
Gynecologic Oncology
Vice Chair of Gynecology and Obstetrics in the National Capital Region, Johns Hopkins University School of Medicine
Join to View Full Profile
10215 Fernwood RoadBethesda, MD 20817
Phone+1 202-243-5295
Fax+1 202-537-4662
Dr. Tanner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins UniversityMBA, Business Administration, 2017 - 2021
- Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 2008 - 2012
- Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 2004 - 2008
- University of Alabama School of MedicineClass of 2004
Certifications & Licensure
- DC State Medical License 2023 - 2026
- IL State Medical License 2018 - 2026
- VA State Medical License 2023 - 2026
- MD State Medical License 2012 - 2025
- FL State Medical License 2018 - 2020
- NY State Medical License 2008 - 2013
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Excellence in Teaching Award Department of GYN/OB, Johns Hopkins University
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- Stakeholder-informed refinement of a behavioral sleep/circadian intervention for gynecologic cancer survivors: an application of the MOST preparation phase.Rina S Fox, Krista Brandon, Terry A Badger, Julia S Gaumond, Ana Acuña Morales
Translational Behavioral Medicine. 2025-01-16 - 8 citationsConsensus on surgical technique for sentinel lymph node dissection in cervical cancer.Nicolò Bizzarri, Andreas Obermair, Heng-Cheng Hsu, Enrique Chacon, Anna Collins
International Journal of Gynecological Cancer. 2024-04-01 - Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer.Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan
Clinical Cancer Research. 2024-03-15
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: